InvestorsHub Logo
Followers 12
Posts 1956
Boards Moderated 0
Alias Born 09/16/2010

Re: None

Tuesday, 09/03/2019 12:11:57 PM

Tuesday, September 03, 2019 12:11:57 PM

Post# of 144814
IMO, I think we get an update on manufacturing, I believe they are almost really there this time, the last PR kind of confirmed this.

Dr. Hidalgo commented, “With PharmaCyte proceeding with the GMP production of the clinical trial product for its LAPC trial, I am more excited than ever to be a part of PharmaCyte’s clinical trial team. I remain enthusiastic about being the PI for the trial. I am also optimistic about the potential that PharmaCyte’s treatment may hold for patients suffering from LAPC and possibly other types of solid cancerous tumors. For example, PharmaCyte’s therapy for cancers involving the pancreas, liver and breast may offer an effective way to specifically target those cancers with little to no side effects from the chemotherapy.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News